---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-25-000126"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2025-10-30T23:59:59+00:00"
generated_at: "2026-05-17T01:27:04.344317+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Stryker Q3 net sales +10.3% to $6.1B; raises FY 2025 guidance

## Summary
- Reported EPS $2.22 (+2.8%); adjusted EPS $3.19 (+11.1%).
- Organic net sales +9.5% (volume +9.1%, price +0.4%); MedSurg/Neuro +8.4% organic.
- Orthopaedics organic +11.4% (ex-divested Spinal +12.5%); adjusted op margin 25.6% (+90 bps).
- FY 2025 guidance raised: organic sales growth 9.8%-10.2%, adj EPS $13.50-$13.60.

## SEC filing metadata
- accession: 0000310764-25-000126
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2025-10-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076425000126/0000310764-25-000126-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076425000126/syk-20251030.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-25-000126
- JSON: https://secwatch.observer/filing/0000310764-25-000126.json
- Plain text: https://secwatch.observer/filing/0000310764-25-000126.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.